logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Minoru Fukuda

This inventor holds 24 USPTO granted patents, primarily in Biotechnology Research. Top assignees: La Jolla Cancer Research Foundation, Boehringer Mannheim Gmbh, The Burnham Institute. Active years: 1990-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Fukuda. Retrieved from https://idiyas.com/inventor/minoru-fukuda-llv5aek2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 91.7

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 238(Granted Patents)


Company Filing History:

goldMedal13 out of 151 
 
La Jolla Cancer Research Foundation
 patents
silverMedal4 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
bronzeMedal4 out of 94 
 
The Burnham Institute
 patents
4. 2 out of 55 
 
Burnham Institute for Medical Research
 patents
5. 1 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
6. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2011

Loading Chart...
Areas of Expertise:
Antimicrobial Carbohydrates
Tumor Metastasis Inhibition
Polypeptides
Nucleic Acids
Acetyl-Coenzyme-A Transporters
Sulfotransferase
Ig Fusion Proteins
Antibodies
T-Cell Dysfunction
Polysialyl Transferases
Glycans
24 patents (USPTO):Explore Patents
1. 7871793 - Antimicrobial carbohydrates and methods of using same (2011-01-18),
2. 7470658 - Methods for inhibiting tumor metastasis, and peptides useful therefor (2008-12-30),
3. 7291491 - Polypeptides (2007-11-06),
4. 6566497 - Nucleic acid encoding a family of acetyl-coenzyme-a transporter proteins, and products related thereto (2003-05-20),
5. 6537553 - Leukosialin: Ig fusion proteins (2003-03-25),
6. 6451969 - Methods for inhibiting tumor metastasis, and peptides useful therfor (2002-09-17),
7. 6420149 - Polypeptides (2002-07-16),
8. 6323332 - Sulfotransferase for HNK-1 glycan (2001-11-27),
9. 6136580 - .beta.-1-6-N-acetylglucosaminyltransferase that forms core 2, core 4 and (2000-10-24),
10. 6020201 - Isolated nucleic acid molecules which encode mammalian or rodent 2,8 (2000-02-01),
11. 5959078 - Isolated polysialyl transferases (1999-09-28),
12. 5851788 - Nucleic acid encoding a family of acetyl-coenzyme-A transporter (1998-12-22),
13. 5849904 - Isolated nucleic acid molecules which hybridize to polysialyl (1998-12-15),
14. 5766910 - Expression of the developmental I antigen by a cloned human cDNA (1998-06-16),
15. 5747326 - Isolated nucleic acid molecules which encode mammalian .alpha.2,8 (1998-05-05),

Title: The Innovative Contributions of Minoru Fukuda in the Field of Biomedicine

Introduction

Minoru Fukuda, based in San Diego, CA, is a notable inventor with an impressive portfolio of 24 patents. His innovative work primarily focuses on biomedicine, particularly in the areas of antimicrobial compounds and cancer research. His inventions are instrumental in addressing significant health issues, including gastric ulcers and tumor metastasis.

Latest Patents

Among his latest patents, Fukuda has made remarkable strides with his inventions related to antimicrobial carbohydrates. One of his patents provides compositions that inhibit the growth of bacteria, specifically those that can lead to gastric ulcers. This patent also discusses the use of transgenic organisms capable of producing these beneficial compositions, along with methods aimed at treating or preventing gastric ulcers in humans. Additionally, another patent introduces peptides that bind to a member of the mammalian selectin family. These peptides serve to inhibit the adhesion of certain cells, effectively providing methods for reducing tumor cell metastasis.

Career Highlights

Throughout his career, Minoru Fukuda has collaborated with prestigious organizations such as the La Jolla Cancer Research Foundation and Boehringer Mannheim GmbH. His work in these institutions has been pivotal in advancing research related to cancer and infectious diseases, contributing to significant breakthroughs in the field.

Collaborations

Fukuda has worked alongside talented individuals like Marti F Bierhuizen and Jun Nakayama. These collaborations have enabled the pooling of expertise and perspectives, further enhancing the quality and innovation of their research endeavors.

Conclusion

Minoru Fukuda's contributions to the scientific community through his inventions are invaluable. His 24 patents reflect a commitment to addressing critical health challenges, particularly in the realms of antimicrobial treatments and cancer prevention. As a distinguished inventor, Fukuda continues to inspire future innovations that may greatly enhance human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…